title: A Renewed Emphasis on Therapeutic Angiogenesis Research for CAD.
abstract: Up to now, unblocking clogged arteries for so-called no-option patients with coronary artery disease or congestive heart failure hasn't been possible. Angiogenesis research, despite previous setbacks, may be the answer for this group of patients.
authors.affiliation: Jack Jacobs, PhD, is chief scientific officer and chief operating officer at CardioVascular BioTherapeutics, in Las Vegas.
authors.forename: Jack
authors.initials: J
authors.lastname: Jacobs